Multi-omics evaluation of peritoneal fluid in gastroesophageal cancer (OMEGCA): protocol for a prospective multicentre cohort study to detect occult peritoneal metastases in patients undergoing curative-intent treatment
Multi-omics evaluation of peritoneal fluid in gastroesophageal cancer (OMEGCA): protocol for a prospective multicentre cohort study to detect occult peritoneal metastases in patients undergoing curative-intent treatment
Geraldine Ooi, David I. Watson, Krinal Mori, David S. Liu et al.
Citations
1 citations
Journal
PLoS ONE
Topics
Gastric Cancer Management and Outcomes
Field-Weighted Citation Impact (FWCI)
1.52
article
Multi-omics evaluation of peritoneal fluid in gastroesophageal cancer (OMEGCA): protocol for a prospective multicentre cohort study to detect occult peritoneal metastases in patients undergoing curative-intent treatment
Geraldine Ooi, David I. Watson, Krinal Mori, David S. Liu, Margaret M. Lee, Sarah A. Martin, Zexi Allan, Darren Wong, Stephen Q. Wong, Nicholas J. Clemons, Jeanne Tie, Niall C. Tebbutt, Nicole Winter, Ronald Ma, Markus Trochsler, Yahya Al-Habbal, Katheryn Hall
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
PLoS ONEVol. 20(4)
Institutions
Royal Adelaide Hospital (AU), The University of Melbourne (AU), Flinders University (AU), Northern Health (AU), Austin Hospital (AU), Peter MacCallum Cancer Centre (AU), Flinders Medical Centre (AU), Eastern Health (AU), Queen Elizabeth Hospital (AU), Cancer Trials Australia (AU), Footscray Hospital (AU), Monash Health (AU), Melbourne Health (AU), Olivia Newton-John Cancer Wellness & Research Centre (AU), Austin Health (AU), The University of Adelaide (AU)